PharmaCyte Biotech, Inc.
PMCBNasdaqCIK 1157075HealthcareFiscal year ends Apr 30
Reports and events: 211 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-11-0717:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001683168-22-007359 |
| 2022-10-1416:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-006911 |
| 2022-10-0716:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-22-006803 |
| 2022-09-1416:29 ET | 10-Q | Quarterly reportPeriod 2022-07-31 | 0001683168-22-006394 |
| 2022-08-1618:55 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-22-005782 |
| 2022-08-1517:38 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-22-002477 |
| 2022-07-2817:29 ET | 10-K | Annual reportPeriod 2022-04-30 | 0001683168-22-005189 |
| 2022-07-2817:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-005186 |
| 2022-07-2114:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-005063 |
| 2022-07-1917:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-005036 |
| 2022-07-1117:11 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-22-002213 |
| 2022-07-1116:21 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-004874 |
| 2022-06-2315:40 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-22-002076 |
| 2022-06-1508:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-004361 |
| 2022-06-0721:50 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001683168-22-004190 |
| 2022-04-1307:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001683168-22-002580 |
| 2022-04-0506:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-22-002335 |
| 2022-03-1517:16 ET | 10-Q | Quarterly reportPeriod 2022-01-31 | 0001683168-22-001694 |
| 2022-03-0917:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-22-001550 |
| 2022-03-0120:50 ET | 8-K | 3.01 Delisting notice | 0001683168-22-001345 |
| 2022-02-1717:14 ET | 8-K | 3.01 Delisting notice | 0001683168-22-001119 |
| 2021-12-1417:16 ET | 10-Q | Quarterly reportPeriod 2021-10-31 | 0001683168-21-006337 |
| 2021-11-0407:38 ET | SC 13D | Ownership report, active investor | 0000930413-21-001835 |
| 2021-09-1408:01 ET | 10-Q | Quarterly reportPeriod 2021-07-31 | 0001683168-21-004264 |
| 2021-09-1018:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-21-004199 |
| 2021-08-2306:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-21-003829 |
| 2021-08-1221:58 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-21-003431 |
| 2021-08-1006:03 ET | 10-K | Annual reportPeriod 2021-04-30 | 0001683168-21-003377 |
| 2021-08-0217:12 ET | 8-K | 8.01 Other events | 0001683168-21-003222 |
| 2021-07-1319:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-21-002921 |
| 2021-07-0620:23 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-21-002825 |
| 2021-06-2220:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-21-002661 |
| 2021-06-1521:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-21-002553 |
| 2021-06-0421:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-21-002359 |
| 2021-05-0621:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-21-001793 |
| 2021-03-1217:11 ET | 10-Q | Quarterly reportPeriod 2021-01-31 | 0001683168-21-000925 |
| 2020-12-1116:47 ET | 10-Q | Quarterly reportPeriod 2020-10-31 | 0001683168-20-004267 |
| 2020-10-1616:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-20-003473 |
| 2020-09-1116:27 ET | 10-Q | Quarterly reportPeriod 2020-07-31 | 0001683168-20-003111 |
| 2020-08-1317:05 ET | 10-K | Annual reportPeriod 2020-04-30 | 0001683168-20-002680 |
| 2020-07-2916:34 ET | SC 13D/A | Ownership report, active investor, amended | 0001753926-20-000215 |
| 2020-05-0614:19 ET | SC 13D | Ownership report, active investor | 0001753926-20-000100 |
| 2020-04-0808:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-20-001127 |
| 2020-03-1316:47 ET | 10-Q | Quarterly reportPeriod 2020-01-31 | 0001683168-20-000802 |
| 2020-01-2117:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-20-000204 |
| 2019-12-2316:37 ET | 10-Q | Quarterly reportPeriod 2019-10-31 | 0001683168-19-004051 |
| 2019-11-0817:27 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-19-003515 |
| 2019-10-0316:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-19-003157 |
| 2019-09-1317:16 ET | 10-Q | Quarterly reportPeriod 2019-07-31 | 0001683168-19-002926 |
| 2019-08-2608:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-19-002754 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.